David A. Giljohann
Chief Executive Officer presso EVOQ Therapeutics, Inc.
Profilo
David A.
Giljohann is currently the Chief Executive Officer at EVOQ Therapeutics, Inc. He previously worked as the Chief Technology Officer at Exicure, Inc. from 2021 to 2022.
Prior to that, he was the Chief Operating Officer & Principal Scientist at Exicure Operating Co. from 2012 to 2013.
He also worked as a Founding Scientist at Aurasense LLC.
Dr. Giljohann received his undergraduate and doctorate degrees from Northwestern University.
Posizioni attive di David A. Giljohann
| Società | Posizione | Inizio |
|---|---|---|
EVOQ Therapeutics, Inc.
 EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Chief Executive Officer | 09/01/2023 |
Precedenti posizioni note di David A. Giljohann
| Società | Posizione | Fine |
|---|---|---|
| EXICURE, INC. | Chief Executive Officer | 10/12/2021 |
| Aurasense LLC | Chief Tech/Sci/R&D Officer | 01/01/2009 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Chief Executive Officer | - |
Formazione di David A. Giljohann
| Northwestern University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EXICURE, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Aurasense LLC | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Health Technology |
- Borsa valori
- Insiders
- David A. Giljohann
